NO744459L - - Google Patents
Info
- Publication number
- NO744459L NO744459L NO744459A NO744459A NO744459L NO 744459 L NO744459 L NO 744459L NO 744459 A NO744459 A NO 744459A NO 744459 A NO744459 A NO 744459A NO 744459 L NO744459 L NO 744459L
- Authority
- NO
- Norway
- Prior art keywords
- address
- card
- addresses
- specified
- symbolic
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 claims description 103
- 230000003993 interaction Effects 0.000 claims description 57
- 239000000758 substrate Substances 0.000 claims description 57
- 239000011159 matrix material Substances 0.000 claims description 35
- 230000000694 effects Effects 0.000 claims description 34
- 239000004480 active ingredient Substances 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 22
- 239000003086 colorant Substances 0.000 claims description 10
- 201000010099 disease Diseases 0.000 claims description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- 238000013480 data collection Methods 0.000 claims description 6
- 230000007613 environmental effect Effects 0.000 claims description 5
- 238000012986 modification Methods 0.000 claims description 4
- 230000004048 modification Effects 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 2
- 241000208125 Nicotiana Species 0.000 claims 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims 1
- 230000006870 function Effects 0.000 description 29
- 239000003814 drug Substances 0.000 description 19
- 229940079593 drug Drugs 0.000 description 16
- 239000002075 main ingredient Substances 0.000 description 15
- 239000000470 constituent Substances 0.000 description 10
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 8
- 230000000144 pharmacologic effect Effects 0.000 description 8
- 229960001138 acetylsalicylic acid Drugs 0.000 description 7
- 239000013543 active substance Substances 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 239000000825 pharmaceutical preparation Substances 0.000 description 6
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 5
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 5
- 238000004040 coloring Methods 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 229940116269 uric acid Drugs 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- 238000007792 addition Methods 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 241000238876 Acari Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 229940126575 aminoglycoside Drugs 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000003715 nutritional status Nutrition 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- -1 ampicillin Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229940005494 general anesthetics Drugs 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000010399 physical interaction Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K19/00—Record carriers for use with machines and with at least a part designed to carry digital markings
- G06K19/06—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K21/00—Information retrieval from punched cards designed for manual use or handling by machine; Apparatus for handling such cards, e.g. marking or correcting
- G06K21/04—Information retrieval from punched cards designed for manual use or handling by machine; Apparatus for handling such cards, e.g. marking or correcting in which coincidence of markings is sensed optically, e.g. peek-a-boo system
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K19/00—Record carriers for use with machines and with at least a part designed to carry digital markings
- G06K19/06—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code
- G06K2019/06215—Aspects not covered by other subgroups
- G06K2019/06225—Aspects not covered by other subgroups using wavelength selection, e.g. colour code
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K19/00—Record carriers for use with machines and with at least a part designed to carry digital markings
- G06K19/06—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code
- G06K2019/06215—Aspects not covered by other subgroups
- G06K2019/06271—Relief-type marking
Landscapes
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Theoretical Computer Science (AREA)
- Credit Cards Or The Like (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7344177A FR2254061A1 (en) | 1973-12-11 | 1973-12-11 | Device for determining common data characteristics - uses different signs corresponding to different data |
| FR7400627A FR2283485A2 (fr) | 1973-12-11 | 1974-01-08 | Dispositif pour la determination de caracteristiques a des ensembles de donnees |
| FR7418937A FR2273316A2 (en) | 1973-12-11 | 1974-05-31 | Device for determining common data characteristics - uses different signs corresponding to different data |
| FR7432797A FR2286433A2 (fr) | 1973-12-11 | 1974-09-30 | Dispositif de determination d'interactions dans le domaine pharmaceutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO744459L true NO744459L (de) | 1975-07-07 |
Family
ID=27446250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO744459A NO744459L (de) | 1973-12-11 | 1974-12-10 |
Country Status (16)
| Country | Link |
|---|---|
| AT (1) | AT357351B (de) |
| BR (1) | BR7410368D0 (de) |
| DD (1) | DD115248A5 (de) |
| DE (1) | DE2458453A1 (de) |
| DK (1) | DK640974A (de) |
| ES (1) | ES432797A1 (de) |
| FI (1) | FI354974A (de) |
| GB (1) | GB1500137A (de) |
| HU (1) | HU176641B (de) |
| IL (1) | IL46223A (de) |
| LU (2) | LU71452A1 (de) |
| NL (1) | NL7416150A (de) |
| NO (1) | NO744459L (de) |
| OA (1) | OA04950A (de) |
| SE (1) | SE7415481L (de) |
| TR (1) | TR19240A (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2466054A1 (fr) * | 1978-08-08 | 1981-03-27 | Blanie Paul | Dispositif de memoire et de traitement de donnees de diagnostic |
| EP0020841A1 (de) * | 1979-06-08 | 1981-01-07 | Paul Blanié | Einrichtung zum Speichern und Verarbeiten von Diagnosedaten |
| GB8624808D0 (en) * | 1986-10-16 | 1986-11-19 | Laser Impressions Ltd | Identifying item of printed matter |
-
1974
- 1974-12-10 FI FI3549/74A patent/FI354974A/fi unknown
- 1974-12-10 NO NO744459A patent/NO744459L/no unknown
- 1974-12-10 DK DK640974A patent/DK640974A/da not_active Application Discontinuation
- 1974-12-10 LU LU71452A patent/LU71452A1/xx unknown
- 1974-12-10 SE SE7415481A patent/SE7415481L/ unknown
- 1974-12-10 DE DE19742458453 patent/DE2458453A1/de active Pending
- 1974-12-11 NL NL7416150A patent/NL7416150A/xx not_active Application Discontinuation
- 1974-12-11 DD DD182946A patent/DD115248A5/xx unknown
- 1974-12-11 TR TR19240A patent/TR19240A/xx unknown
- 1974-12-11 OA OA55361A patent/OA04950A/xx unknown
- 1974-12-11 AT AT989574A patent/AT357351B/de not_active IP Right Cessation
- 1974-12-11 BR BR10368/74A patent/BR7410368D0/pt unknown
- 1974-12-11 IL IL46223A patent/IL46223A/xx unknown
- 1974-12-11 ES ES432797A patent/ES432797A1/es not_active Expired
- 1974-12-11 LU LU71458A patent/LU71458A1/xx unknown
- 1974-12-11 GB GB53603/74A patent/GB1500137A/en not_active Expired
- 1974-12-11 HU HU74BA3179A patent/HU176641B/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL46223A0 (en) | 1975-03-13 |
| DE2458453A1 (de) | 1975-07-10 |
| BR7410368D0 (pt) | 1975-09-16 |
| SE7415481L (de) | 1975-06-12 |
| TR19240A (tr) | 1978-07-17 |
| OA04950A (fr) | 1980-10-31 |
| GB1500137A (en) | 1978-02-08 |
| LU71458A1 (de) | 1975-08-20 |
| IL46223A (en) | 1978-06-15 |
| HU176641B (en) | 1981-04-28 |
| DD115248A5 (de) | 1975-09-12 |
| AT357351B (de) | 1980-07-10 |
| DK640974A (de) | 1975-08-25 |
| NL7416150A (nl) | 1975-06-13 |
| FI354974A (de) | 1975-06-12 |
| ATA989574A (de) | 1979-11-15 |
| ES432797A1 (es) | 1977-03-01 |
| LU71452A1 (de) | 1975-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3979839A (en) | Drug interaction system | |
| JP6607185B2 (ja) | 薬剤撮影装置 | |
| US6226564B1 (en) | Method and apparatus for dispensing drugs to prevent inadvertent administration of incorrect drug to patient | |
| EP0480019A1 (de) | Visuelles erinnerungssystem für medikamenteneinnahme | |
| US20090126743A1 (en) | Apparatus and method of a locality specific pre-hospital pediatric medical treatment | |
| JP6879298B2 (ja) | 画像処理プログラム、および、画像処理装置 | |
| US7320483B2 (en) | Medication reminder system | |
| KR100583029B1 (ko) | 조제 지시시스템 | |
| US20050110268A1 (en) | Personalized medication card | |
| JP5638203B2 (ja) | 診療支援装置 | |
| NO744459L (de) | ||
| JP6996107B2 (ja) | 有害事象管理システム、有害事象管理プログラム | |
| US7261206B2 (en) | Medication dosage regimen communication device | |
| Cohen | The role of drug packaging and labeling in medication errors | |
| US3759597A (en) | Method and apparatus for dispensing pharmaceutical doses | |
| Momtahan et al. | Using human factors methods to evaluate the labelling of injectable drugs | |
| KR20090052299A (ko) | 약의 복용여부를 하루의 3시기와 일자별로 표시하는 기능을갖는 약병 | |
| KR20010023067A (ko) | 약봉투 작성 시스템 | |
| CA1065486A (fr) | Dispositif pour la determination de caracteristiques communes a des ensembles de donnees | |
| Raschke et al. | Evaluation of electronic databases used to identify solid oral dosage forms | |
| CN210722140U (zh) | 用药标签 | |
| JP3060146U (ja) | 薬剤識別ラベル | |
| Strieby | Reference files in a pharmaceutical library | |
| TWM660572U (zh) | 智能藥品存儲管理系統 | |
| JPH0863519A (ja) | 服薬指示書および服薬指示書作成装置 |